-
1
المؤلفون: Muhamed-Kheir Taha, Georgina Tzanakaki, Cecilia Fazio, Alexander Pysik, Maria Koliou, Michael Bröker, Stéphane Emonet, Susanne Jacobsson, Anna Skoczynska, Markku Kuusi, Maija Toropainen, Metka Paragi, Maria João Simões, Paola Stefanelli, David Pace
المساهمون: Novartis Vaccines and Diagnostics, Hôpitaux Universitaires de Genève (HUG), Istituto Superiore di Sanità (ISS), Örebro University Hospital [Örebro, Sweden], Ministry of Health [Cyprus], National Institute for Health and Welfare [Helsinki], Mater Dei Hospital [Malta], National Institute of Public Health of the Republic of Slovenia, Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA), National Reference Centre for Bacterial Meningitis [Warsaw, Poland] (NRCBM), National Medicines Institute - Narodowy Instytut Leków [Warsaw] (NIL), National Institute of Public Health and Welfare [Helsinki], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris] (IP), National School of Public Health Athens, Istituto Superiore di Sanita [Rome], Institut Pasteur [Paris]
المصدر: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics, 2015, 11 (9), pp.2281-2286. ⟨10.1080/21645515.2015.1051276⟩
Human Vaccines & Immunotherapeutics, Taylor & Francis, 2015, 11 (9), pp.2281-2286. ⟨10.1080/21645515.2015.1051276⟩مصطلحات موضوعية: Infecções Respiratórias, Invasive Meningococcal Disease, MESH: Topography, Medical, Epidemiology, Disease, Neisseria meningitidis, medicine.disease_cause, Health problems, 0302 clinical medicine, MESH: Aged, 80 and over, IMD, MESH: Child, Prevalence, Immunology and Allergy, 030212 general & internal medicine, Child, MESH: Aged, Aged, 80 and over, 0303 health sciences, Meningococcal, MESH: Middle Aged, MESH: Meningitis, Meningococcal, Men, Middle Aged, MESH: Infant, 3. Good health, Europe, Invasive meningococcal disease, MESH: Young Adult, Child, Preschool, Geographic regions, Doença Meningocócica, epidemiology, Topography, Medical, Neisseria meningitidis, Serogroup Y, Meningitis, meningococcal, Adult, medicine.medical_specialty, Meningococcal Serogroup Y, Adolescent, Immunology, Meningitis, Meningococcal, Neisseria meningitidis serogroup Y, 03 medical and health sciences, Young Adult, Age Distribution, medicine, Humans, MESH: Age Distribution, MESH: Prevalence, Aged, Pharmacology, MESH: Adolescent, MESH: Humans, meningococcal serogroup Y, 030306 microbiology, business.industry, invasive meningococcal disease, MESH: Child, Preschool, Infant, MESH: Adult, medicine.disease, bacterial infections and mycoses, Virology, MESH: Europe/epidemiology, Commentary, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Neisseria meningitidis, Serogroup Y, Demography
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbbd15ce676bbc97060b0034c9f46f2Test
https://europepmc.org/articles/PMC4635851Test/ -
2
المؤلفون: Markku Kuusi, Maija Toropainen, Anna Skoczynska, Georgina Tzanakaki, Michael Bröker, Susanne Jacobsson, David Pace, Muhamed-Kheir Taha, Maria João Simões
المساهمون: Novartis Vaccines and Diagnostics, Örebro University Hospital [Örebro, Sweden], National Institute for Health and Welfare [Helsinki], Mater Dei Hospital [Malta], Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA), National Reference Centre for Bacterial Meningitis [Warsaw, Poland] (NRCBM), National Medicines Institute - Narodowy Instytut Leków [Warsaw] (NIL), Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], National Meningitis Reference Laboratory, National School of Public Health Athens, M.B. is full-time employee of Novartis Vaccines and Diagnostics, a manufacturer of various meningococcal vaccines. D.P. has received grants from GlaxoSmithKline, Novartis Vaccines and Pfizer to attend scientific meetings. A.S. has received assistance to attend scientific meetings and honoraria for lecturing and her laboratory has received research funding from GlaxoSmithKline, Novartis and Wyeth/Pfizer., Institut Pasteur [Paris] (IP)
المصدر: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics, Taylor & Francis, 2014, 8 (12), pp.1907-1911. ⟨10.4161/hv.21794⟩
Human Vaccines & Immunotherapeutics, 2014, 8 (12), pp.1907-1911. ⟨10.4161/hv.21794⟩مصطلحات موضوعية: Adult, Male, Infecções Respiratórias, medicine.medical_specialty, Adolescent, Epidemiology, Immunology, Meningococcal Disease, Meningitis, Meningococcal, Meningococcal disease, medicine.disease_cause, Communicable Diseases, Emerging, Neisseria meningitidis serogroup Y, Young Adult, Immunology and Allergy, Medicine, Humans, Pharmacology, meningococcal disease, Surveillance, business.industry, Neisseria meningitidis, Incidence (epidemiology), Incidence, serogroup Y, Middle Aged, medicine.disease, Virology, 3. Good health, Serogroup Y, Europe, Invasive meningococcal disease, Epidemiological surveillance, Geographic regions, Commentary, surveillance, Female, epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Neisseria meningitidis, Serogroup Y
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f283beba851c495a53a2c57ba96893bTest
https://hal-pasteur.archives-ouvertes.fr/pasteur-02085551Test -
3
المؤلفون: Muhamed-Keir Taha, Maria João Simões, Maria Koliou, Suzana Bukovski, Susanne Jacobsson, Georgina Tzanakaki, Davor Culic, Markku Kuusi, Maija Toropainen, Anna Skoczynska, Michael Bröker
المساهمون: Novartis Vaccines and Diagnostics, University Hospital for Infectious Diseases [Zagreb], Haemophilus and Meningococcus Reference Laboratory [Srbija], Institute of Public Health of Serbia (BATUT), Örebro University Hospital [Örebro, Sweden], Ministry of Health [Cyprus], National Institute for Health and Welfare [Helsinki], Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA), National Reference Centre for Bacterial Meningitis [Warsaw, Poland] (NRCBM), National Medicines Institute - Narodowy Instytut Leków [Warsaw] (NIL), Infections Bactériennes Invasives, Institut Pasteur [Paris] (IP), National Meningitis Reference Laboratory, National School of Public Health Athens, Institute for Public Health [Serbia], Institut Pasteur [Paris]
المصدر: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics, 2014, 10 (6), pp.1725-1728. ⟨10.4161/hv.28206⟩
Human Vaccines & Immunotherapeutics, Taylor & Francis, 2014, 10 (6), pp.1725-1728. ⟨10.4161/hv.28206⟩مصطلحات موضوعية: medicine.medical_specialty, MESH: Topography, Medical, Adolescent, Immunology, Meningococcal vaccine, MESH: Meningococcal Infections, Meningococcal disease, medicine.disease_cause, 03 medical and health sciences, 0302 clinical medicine, MESH: Child, Epidemiology, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Child, MESH: Adolescent, Pharmacology, 0303 health sciences, MESH: Humans, 030306 microbiology, business.industry, serogroup Y, Neisseria meningitidis, invasive meningococcal disease, meningococcal vaccines, medicine.disease, Virology, 3. Good health, Europe, Meningococcal Infections, Invasive meningococcal disease, surveillance, Epidemiological surveillance, Geographic regions, Commentary, epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Topography, Medical, MESH: Europe, MESH: Neisseria meningitidis, Serogroup Y, business, Neisseria meningitidis, Serogroup Y
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f91e50344c79937222a7a5c17e1b67Test
https://europepmc.org/articles/PMC5396223Test/